Bluejay Diagnostics, Inc. (BJDX) financial statements and ratios from SEC XBRL: revenue $97559.00 (TTM), net margin -7019.8%, revenue growth -33.1% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $97559.00 |
| Net Margin | -7019.8% |
| Revenue Growth (YoY) | -33.1% |
| EPS Growth (YoY) | -86.6% |
| FCF Growth (YoY) | -23.4% |
| Price / Book | 0.44 |
| Price / Sales | 50.48 |
| FCF Yield | -157.2% |
| Altman Z-Score | -10.17 (distress) |
| Sector P/E (Healthcare) | 21.6 |
BJDX overview · BJDX earnings · BJDX KPIs · BJDX investor relations · BJDX ownership · BJDX peers · BJDX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.